Pharmacists in Henrico, Virginia


61 Pharmacists found in Henrico
male pharmacist

Dr. Osmin Centeno


Pharmacist
3460 Pump Rd, Henrico, VA 23233
804-253-9867    

male pharmacist

Dr. Paul Caudill, PHARMD


Pharmacist
11120 Patterson Ave, Henrico, VA 23238
804-740-0238    

female pharmacist

Rebecca Milagro Fore


Pharmacist
11895 W Broad St, Henrico, VA 23233
804-360-3268     804-360-3848



female pharmacist

Rebecca Barnes, PHARMD, RPH


Pharmacist
1574 E Parham Rd, Henrico, VA 23228
804-553-3970     804-553-3971

female pharmacist

Dr. Roxanne Schultz, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
4816 S Laburnum Ave, Henrico, VA 23231
804-226-0010    

male pharmacist

Dr. Ryan Phillip Gibson, PHARMD


Pharmacist
1301 E Nine Mile Rd, Henrico, VA 23075
804-737-6493    

female pharmacist

Sally Eby, PHARMACIST


Pharmacist
3656 Mayland Ct, Henrico, VA 23233
804-897-6447     804-897-6449

male pharmacist

Scott Buff


Pharmacist
3821 Somerbrook Ct, Henrico, VA 23233
804-928-1755    

male pharmacist

Thomas Fattah


Pharmacist
11500 W Broad St, Henrico, VA 23233
804-360-2531    

male pharmacist

Timothy Hanson Baumgardner, PHARMD


Pharmacist
9167 Staples Mill Rd, Henrico, VA 23228
804-672-6613     804-672-0195

female pharmacist

Dr. Tonya Coles Davis, PHARMD


Pharmacist - Pharmacotherapy
7708 Balla Ct, Henrico, VA 23228
804-873-4541    

female pharmacist

Touhida Zannat


Pharmacist
9001 Staples Mill Rd, Henrico, VA 23228
804-672-5350    

female pharmacist

Yang Huang, PHARM D


Pharmacist
12200 Wegmans Blvd, Henrico, VA 23233
804-377-4146    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.